Form 4: Modular Medical Director Steven Felsher Acquires Shares and Options
SEC Form 4 Filing
Director Steven Felsher acquired 750 shares of common stock and options to purchase 7,500 shares of common stock in Modular Medical, Inc.
Summary
- On September 30, 2024, Steven Felsher, a director of Modular Medical, Inc., acquired 750 shares of common stock.
- These shares were issued to Felsher in accordance with the company's Outside Director Compensation Plan.
- Felsher also acquired an option to purchase 7,500 shares of common stock at an exercise price of $2.28.
- The option was granted under the same compensation plan and was fully vested and exercisable on the grant date, expiring on September 30, 2034.
- Following these transactions, Felsher directly owns 127,677 shares of Modular Medical, Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares and options suggests confidence in the company, but it's a routine transaction.
Positives
- The acquisition of shares and options by a director signals confidence in the company's future.
- The Outside Director Compensation Plan aligns director interests with those of shareholders.
Future Outlook
The document does not contain specific forward-looking statements, but the director's acquisition suggests a positive outlook.
Industry Context
This type of filing is standard for corporate insiders and reflects compensation practices within publicly traded companies.
Comparison to Industry Standards
- Director compensation plans involving stock options are common across the industry to align the interests of directors with shareholders.
- The specific terms of the option grant (exercise price, vesting schedule, expiration date) would need to be compared to similar companies in the medical device sector to assess its competitiveness.
- Companies like Dexcom and Insulet also utilize equity-based compensation for their directors.
Related Party Transactions
- The issuance of shares and options to Steven Felsher, a director, is a related party transaction.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of transaction: acquisition of common stock and stock options. |
| 09/30/2034 | Expiration date of the stock options. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.